Clinical trial
Evaluation of the Accuracy and Precision of the INRatio® Prothrombin Time (PT) Monitoring System With New INRatio Test Strip Designed for Low Sample Volume and Heparin Insensitivity
NCT01037270 is registered in ClinicalTrials.gov with Abbott RDx Cardiometabolic as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of the Accuracy and Precision of the INRatio® Prothrombin Time (PT) Monitoring System With New INRatio Test Strip Designed for Low Sample Volume and Heparin Insensitivity
- Lead sponsor
- Abbott RDx Cardiometabolic
- Phase
- Observational
- Overall status
- Completed
- Start date
- August 31, 2009
- Completion date
- June 30, 2010
- Enrollment
- 271 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.
atrial fibrillation, deep vein thrombosis, pulmonary embolism